Chapter 64. Lung and Thymic Neuroendocrine Tumors

  1. Ian D. Hay BSc, MB, PhD, FACE, FACP, FRCP, FRCPI (Hon) Professor of Medicine Consultant in Endocrinology and Internal Medicine2,3,
  2. John A.H. Wass MA, MD, FRCP Professor of Endocrinology Consultant Physician4
  1. Dan Granberg MD, PhD,
  2. Kjell Öberg MD, PhD Professor of Endocrine Oncology

Published Online: 27 JAN 2009

DOI: 10.1002/9781444300222.ch64

Clinical Endocrine Oncology, Second Edition

Clinical Endocrine Oncology, Second Edition

How to Cite

Granberg, D. and Öberg, K. (2009) Lung and Thymic Neuroendocrine Tumors, in Clinical Endocrine Oncology, Second Edition (eds I. D. Hay and J. A.H. Wass), Blackwell Publishing, Ltd, Oxford, UK. doi: 10.1002/9781444300222.ch64

Editor Information

  1. 2

    Dr R.F. Emslander Professor of Endocrinology Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

  2. 3

    Mayo Clinic, Rochester, Minnesota, USA

  3. 4

    University of Oxford, Churchill Hospital, Oxford, UK

Author Information

  1. Department of Medical Sciences and Department of Endocrine Oncology, University Hospital, Uppsala, Sweden

Publication History

  1. Published Online: 27 JAN 2009
  2. Published Print: 15 APR 2008

ISBN Information

Print ISBN: 9781405145848

Online ISBN: 9781444300222

SEARCH

Keywords:

  • neuroendocrine lung tumors (bronchial carcinoids);
  • thymic neuroendocrine tumors (carcinoids) (TNETS);
  • multiple endocrine neoplasia type 1 syndrome;
  • histopathology and immunohistochemistry;
  • genetic alterations

Summary

This chapter contains sections titled:

  • Introduction

  • Neuroendocrine lung tumors (bronchial carcinoids)

  • Genetic alterations

  • Clinical presentation

  • Diagnosis

  • Differential diagnoses

  • Treatment

  • Prognosis

  • Thymic neuroendocrine tumors (carcinoids) (TNETS)

  • Genetic alterations

  • Clinical presentation

  • Diagnosis

  • Treatment

  • Prognosis

  • References